Effects of hesperetin on the production of inflammatory mediators in IL-1β treated human synovial cells

Cellular Immunology

Volumn 264, Issue 1, 2010, Pages 1-3

  Choi, Eun Mi ^a   Lee, Young Soon ^a  

^a Kyung Hee University   (South Korea)

Author keywords

Cytokines; Hesperetin; Matrix metalloproteinases; Mitogen activated protein kinases; SW982

Indexed keywords

AUTACOID; HESPERETIN; INTERLEUKIN 1BETA; INTERLEUKIN 6; MITOGEN ACTIVATED PROTEIN KINASE; STRESS ACTIVATED PROTEIN KINASE; STROMELYSIN;

ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; ENZYME ACTIVATION; ENZYME INHIBITION; ENZYME LINKED IMMUNOSORBENT ASSAY; ENZYME SYNTHESIS; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROTEIN SYNTHESIS INHIBITION; SYNOVIOCYTE;

ANTI-INFLAMMATORY AGENTS; ARTHRITIS, RHEUMATOID; CELL LINE; ENZYME ACTIVATION; EXTRACELLULAR SIGNAL-REGULATED MAP KINASES; FRUIT; HESPERIDIN; HUMANS; INFLAMMATION MEDIATORS; INTERLEUKIN-1; INTERLEUKIN-6; MAP KINASE KINASE 4; MATRIX METALLOPROTEINASE 3; SIGNAL TRANSDUCTION; SYNOVIAL MEMBRANE;

EID: 77954145021     PISSN: 00088749     EISSN: 10902163     Source Type: Journal    
DOI: 10.1016/j.cellimm.2010.05.006     Document Type: Article

References (10)

1. Feldmann M., Brennan F.M., Maini R.N. Role of cytokines in rheumatoid arthritis. Annu. Rev. Immunol. 1996, 14:397-440.
2. Koch A.E., Kunkel S.L., Harlow L.A., Johnson B., Evanoff H.L., Haines G.K. Enhanced production of monocyte chemoattractant protein-1 in rheumatoid arthritis. J. Clin. Invest. 1992, 90:772-779.
3. Pap T., Muller-Ladner U., Gay R.E., Gay S. Fibroblast biology. Role of synovial fibroblasts in the pathogenesis of rheumatoid arthritis. Arthritis Res. 2000, 2:361-367.
4. Robinson M.J., Cobb M.H. Mitogen-activated protein kinase pathways. Curr. Opin. Cell Biol. 1997, 9:180-185.
5. Seger R., Krebs E.G. The MAPK signaling cascade. FASEB J. 1995, 9:726-735.
6. Yamazaki T., Yokoyama T., Akatsu H., Tukiyama T., Tokiwa T. Phenotypic characterization of a human synovial sarcoma cell line, SW982, and its response to dexamethasone. In Vitro Cell Dev. Biol. Anim. 2003, 39:337-339.
7. Yamanishi Y., Firestein G.S. Pathogenesis of rheumatoid arthritis: the role of synoviocytes. Rheum. Dis. Clin. North Am. 2001, 27:355-371.
8. Ito A., Nose T., Takahashi S., Mori Y. Cyclooxygenase inhibitors augment the production of promatrix metalloproteinase 9 (progelatinase B) in rabbit articular chondrocytes. FEBS Lett. 1995, 360:75-79.
9. Jue D.M., Jeon K.I., Jeong J.Y. Nuclear factor kappa B (NF-κB) pathway as a therapeutic target in rheumatoid arthritis. J. Korean Med. Sci. 1999, 14:231-238.
10. Han Z., Boyle D.L., Chang L., Bennett B., Karin M., Yang L., Manning A.M., Firestein G.S. C-Jun N-terminal kinase is required for metalloproteinase expression and joint destruction in inflammatory arthritis. J. Clin. Invest. 2001, 108:73-81.